Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis

To systematically assess the effect of metformin on colorectal cancer (CRC) risk and mortality in type 2 diabetes mellitus (T2DM) patients. We conducted a systematic search of PubMed, Web of Science, and the Cochrane Library databases for relevant articles before August 2015. Two investigators ident...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicine (Baltimore)
Hlavní autoři: He, Xing-kang, Su, Ting-ting, Si, Jian-min, Sun, Lei-min
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Health 2016
Témata:
4500
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4998616/
https://ncbi.nlm.nih.gov/pubmed/26886616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002749
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky